Omega 3 Visolie

Omega 3 vloeibaar bevat moleculair gedistilleerde visolie uit de Noord Atlantische wateren.

Omega 3 vloeibaar bevat hoge hoeveelheden EPA en DHA.

Aanbevolen gebruik
1 eetlepel (10 ml)

Dosering
Dosering 1 eetlepel (10 ml)

Hoeveelheid per dosering % DH
Visolie 8900mg†
EPA 1602mg
DHA 1068mg

† ADH niet vastgesteld

Overige Ingrediënten
Lemon of Orange

Opmerkingen
Bewaar op een droge, donkere plaats.
Na opening bewaren in de koelkast

 

 

 

References:

  • Djousse L, Arnett DK, Carr JJ, et al. Dietary linolenic acid is inversely associated with calcified atherosclerotic plaque in the coronary arteries: the National Heart, Lung, and Blood Institute Family Heart Study. Circulation 2005;111:2921-6.
  • Djousse L, Arnett DK, Pankow JS, et al. Dietary linolenic acid is associated with a lower prevalence of hypertension in the NHLBI Family Heart Study. Hypertension 2005;45:368-73.
  • Brouwer IA, Katan MB, Zock PL. Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a meta-analysis. J Nutr 2004;134:919-22.
  • Nemets B, Stahl Z, Belmaker RH. Addition of omega-3 fatty acid to maintenance medication treat- ment for recurrent unipolar depressive disorder. Am J Psychiatry 2002;159:477-9.
  • Lucas M, Asselin G, Merette C, et al. Effects of ethyl-eicosapentaenoic acid omega-3 fatty acid supplementation on hot flashes and quality of life among middle-aged women: a double-blind, placebo-controlled, randomized clinical trial. Menopause 2009;16:357-66.
  • Mayser P, Mrowietz U, Arenberger P, et al. Omega-3 fatty acid-based lipid infusion in patients with chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, multicenter trial. J Am Acad Dermatol 1998;38:539-47.
  • Foster RH, Hardy G, Alany RG Borage oil in the treatment of atopic dermatitis. Nutrition. 2010 Jul- Aug;26(7-8):708-18.
  • Song C; Zhao S, Omega-3 fatty acid eicosapentaenoic acid. A new treatment for psychiatric and neurodegenerative diseases: a review of clinical investigations. Expert Opin Investig Drugs – 01- OCT-2007; 16(10): 1627-38.
  • Surette ME; Stull D; Lindemann J, The impact of a medical food containing gammalinolenic and eicosapentaenoic acids on asthma management and the quality of life of adult asthma patients. Curr Med Res Opin – 01-FEB-2008; 24(2): 559-67
  • Chapkin RS; Kim W; Lupton JR; McMurray DN. Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation. Prostaglandins Leukot Essent Fatty Acids – 01-AUG-2009; 81(2-3): 187-91
  • Fetterman JW Jr; Zdanowicz MM, Therapeutic potential of n-3 polyunsaturated fatty acids in disease. Am J Health Syst Pharm – 1-JUL-2009; 66(13): 1169-79
  • Surette ME, The science behind dietary omega-3 fatty acids. CMAJ – 15-JAN-2008; 178(2): 177-80 13. Saugstad LF Are neurodegenerative disorder and psychotic manifestations avoidable brain dysfunctions with adequate dietary omega-3? Nutr Health – 01-JAN-2006; 18(2): 89-101
  • Valentine RC, Valentine DL. Omega-3 fatty acids in cellular membranes: a unified concept Prog Lipid Res. 2004 Sep;43(5):383-402.
  • Kidd PM. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural- functional synergies with cell membrane phospholipids. Altern Med Rev. 2007 Sep;12(3):207-27. 16. Calder PC. The relationship between the fatty acid composition of immune cells and their function. Prostaglandins Leukot Essent Fatty Acids. 2008 Sep-Nov;79(3-5):101-8. Epub 2008 Oct 23
  • Litman, B. J., et al . The role of docosahexaenoic acid containing phospholipids in modulating G protein-coupled signaling pathways : visual transduction. J. Mol. Neurosci. 16(2-3):237-242, 2001. 18. Yashodhara BM; Umakanth S; Pappachan JM; Bhat SK; Kamath R; Choo BH. Omega-3 fatty acids: a comprehensive review of their role in health and disease. Postgrad Med J – 01-FEB-2009; 85(1000): 84-90
  • Calder PC. N-3 polyunsaturated fatty acids, inflammation and immunity: pouring oil on troubled waters or another fishy tale? Nutr Res 2001;21:309-41.
  • Bunea R, El Farrah K, Deutsch L. Evaluation of the effects of Neptune Krill Oil on the clinical course of hyperlipidemia. Altern Med Rev 2004;9:420-8.
  • Studer M, Briel M, Leimenstoll B, et al. Effect of different antilipidemic agents and diets on mortality: a systematic review. Arch Intern Med 2005;165:725-30.
  • Yzebe D, Lievre M. Fish oils in the care of coronary heart disease patients: a meta-analysis of randomized controlled trials. Fundam Clin Pharmacol 2004;18:581-92.
  • Sampalis F, Bunea R, Pelland MF, et al. Evaluation of the effects of Neptune Krill Oil on the management of premenstrual syndrome and dysmenorrhea. Altern Med Rev 2003;8:171-9.
  • Deutsch L. Evaluation of the effect of Neptune Krill Oil on chronic inflammation and arthritic symptoms. J Am Coll Nutr 2007;26:39-48.